Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous electroencephalogram (EEG) monitoring ...

The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG ...

Medically reviewed by Nicholas R. Metrus, MD Stress can cause seizures or seizure-like activity in people with or without ...

2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate epilepsy ...

Epiminder announced that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring ...

Epiminder noted that the Minder system addresses the limitations of existing EEG technologies by offering actionable diagnostic information, which is crucial for the management of epilepsy.